# Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19).

> **NCT06279910** · — · COMPLETED · sponsor: **Complejo Hospitalario Universitario de Albacete** · enrollment: 230 (actual)

## Conditions studied

- SARS-CoV 2 Pneumonia

## Interventions

- **DRUG:** Calcifediol

## Key facts

- **NCT ID:** NCT06279910
- **Lead sponsor:** Complejo Hospitalario Universitario de Albacete
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-21
- **Primary completion:** 2024-03-21
- **Final completion:** 2024-04-25
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06279910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06279910, "Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19).". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06279910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*